A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in COVID-19 patients with Regular Intravenous Immunoglobulin Therapy
The Journal of Infectious Diseases (2021) - Comments
pubmed: 33585890  doi: 10.1093/infdis/jiab098  issn: 0022-1899  issn: 1537-6613 

Raman R S, Vijaykumar Bhagwan Barge, Anil Kumar Darivenula, Himanshu Dandu, Rakesh R Kartha, Varun Bafna, Vishaly T Aravinda, Thummala C Raghuram